Clinical Trials Logo

Clinical Trial Summary

Recent evidence supports lymphatic regulation of tissue sodium handling, however fundamental gaps persist in knowledge regarding the role of lymphatics in human diseases of sodium dysregulation. The goal of this work is to apply novel, noninvasive imaging tools to measure relationships between lymphatic function and tissue sodium in patients with well-characterized lymphedema. Findings are intended to inform mechanisms of lymphatic clearance of tissue sodium, and provide novel imaging biomarkers of lymphedema progression and treatment response.


Clinical Trial Description

The overall goal of this work is to apply and evaluate novel, noninvasive MRI technologies sensitive to sodium and lymphatic circulation in patients with well-characterized lymphatic disease. The results will clarify mechanisms of lymphatic clearance of tissue sodium, and evaluate novel biomarkers of lymphedema risk, progression, and treatment response. Recent evidence supports that lymphatics regulate interstitial sodium levels. When lymphatic clearance is impaired, hypertonic interstitial sodium results in tissue swelling, skin sodium storage, and poor blood pressure control. When lymphatic clearance is impaired in rodent models of lymphedema, lymph stasis and inflammation ensue, leading to tissue remodeling and fibrosis. These data suggest, but do not confirm, that impaired lymphatic clearance contributes to tissue sodium storage and fibrosis. However, this possibility has not been investigated rigorously owing to a lack of clinically-feasible measurement tools sensitive to sodium and lymphatics in humans. To address these gaps in knowledge, the investigators have developed a noninvasive MR lymphangiography (MRL) approach to quantify lymphatic vasculature in patients with unilateral lymphedema of the upper-extremities. They confirmed lateralized lymph stasis and enlarged lymphatic collector cross-sectional area that reduced following manual lymphatic drainage therapy. In parallel to these studies, the investigators optimized noninvasive sodium 23Na MRI for measurement of tissue sodium content (TSC) in the legs of patients with lymphatic insufficiency due to lipedema. In preliminary data, they demonstrate these methods together for the first time in patients with cancer-related lower-extremity lymphedema (LEL) who display significantly elevated skin TSC compared to controls (24.2±6.8 vs. 14.2±1.8 mmol/L, p<0.001, effect size Cohen's d=1.2). Evidence of lymphatic impairment on MRL and tissue sodium deposition are differential in patients with increasing disease severity, and modified by lymphatic complete decongestive therapy (CDT), motivating the following hypotheses: Hypothesis (1): Skin TSC inversely correlates with lymphatic flow velocity; lymphatic flow velocity reduces and TSC increases following LN removal in patients at risk for lymphedema. Hypothesis (2): Skin TSC positively correlates with lymphedema stage; subcutaneous sodium co-localizes with fibrotic tissue in patients with lymphedema and fibrosis. Hypothesis (3): Skin TSC decreases and lymphatic flow velocity increases after CDT in affected limbs with LEL; imaging metrics are reproducible in healthy volunteers. Impact: Results will demonstrate relationships between tissue sodium and lymphatic dysfunction in human disease using noninvasive MRI technologies. This will outline clinically-feasible biomarkers of lymphedema risk, progression, and treatment response which could have significance for future clinical trials that seek to evaluate the impact of emerging lymphatic therapies on tissue sodium storage. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05242900
Study type Observational
Source Vanderbilt University Medical Center
Contact Study coordinator
Phone 615-875-9935
Email salt@vumc.org
Status Recruiting
Phase
Start date October 10, 2021
Completion date December 2025

See also
  Status Clinical Trial Phase
Terminated NCT04858230 - LymphoPilot Test for Limb Lymphedema N/A
Completed NCT05507346 - A Clinical Study to Evaluate the Effectiveness of a Novel Portable Non-Pneumatic Active Compression Device vs. an Advanced Pneumatic Compression Device for Treating Lower Extremity Lymphedema N/A
Recruiting NCT05270629 - Supermicrosurgical Lymphvenous Bypass Intervention for Treatment
Completed NCT03653819 - High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs N/A
Not yet recruiting NCT05609526 - Inspiratory and Calf Muscles Training in Patients With Leg Lymphedema N/A
Completed NCT05193357 - Home-based Intermittent Pneumatic Compression Therapy for Gynecologic Cancer N/A
Recruiting NCT06204510 - Effects of Complex Decongestive Therapy on Proprioception, Balance and Tactile Sense N/A
Completed NCT04588493 - Secondary Lymphedema Due to Human Adjuvant Disease
Not yet recruiting NCT06438133 - Digital Supported Compression Bandaging in Patients With Chronic Edema in the Lower Limbs
Completed NCT05485454 - A Preference Study of Two Pneumatic Compression Devices for Patients With Lower Limb Lymphedema N/A
Completed NCT05456568 - LymphAssistTM at Home (LAAH) N/A
Completed NCT05509062 - Establishing Guidelines for Manual Lymphatic Drainage N/A
Completed NCT04252690 - Physiological Study to Assess Mechanism of Action of MOBIDERM® in Lower-limb Lymphedema Patients N/A
Completed NCT05666947 - Effectiveness of Two Exercises in Preventing Lower-Limb Lymphedema After Gynecological Cancer Surgery N/A
Recruiting NCT06082349 - The N-LVA Study: RCT Comparing LVA vs. Sham Surgery in Cancer-related Lymphedema N/A
Not yet recruiting NCT05970068 - Hydrophobic Tubes for the Treament of Lower and Upper Limb Lymphedema N/A